Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Jason P. Stanko, Ph.D.

Biologist

Jason P. Stanko, Ph.D.
Jason P. Stanko, Ph.D.
Biologist
Tel 984-287-4190
jason.stanko@nih.gov
P.O. Box 12233
Mail Drop K2-07
Durham, N.C. 27709

Jason Stanko, Ph.D., serves as a Project Officer/Contract Officer's Representative in the Program Operations Branch of the National Toxicology Program (NTP). Stanko assists with the administration and monitoring of contracts for reproductive and developmental toxicology and toxicokinetic studies as well as the analyses of existing scientific literature. He aids in the design, conduct, interpretation, and reporting of the toxicology and toxicokinetic studies. The data generated from these studies serve as a resource to state and federal regulatory agencies for predicting potential health effects in humans.

Stanko received a B.S. in biochemistry from University of North Carolina at Chapel Hill and a Ph.D. in toxicology from the University of Alabama at Birmingham. Prior to joining the Program Operations Branch, he worked in the National Health Effects and Environmental Research Laboratory of the US EPA and in the Reproductive and Endocrinology branch of the National Toxicology Program Laboratory.

Selected Publications

  1. Stanko JP, Fenton SE. 2017. Quantifying Branching Density in Rat Mammary Gland Whole-mounts Using the Sholl Analysis Method. J Vis Exp. Jul 12:(125). doi: 10.3791/55789. [Abstract Stanko JP, Fenton SE. 2017. Quantifying Branching Density in Rat Mammary Gland Whole-mounts Using the Sholl Analysis Method. J Vis Exp. Jul 12:(125). doi: 10.3791/55789.]
  2. Stanko JP, Kissling GE, Chappell VA, Fenton SE. 2016. Differences in the Rate of in situ Mammary Gland Development and Other Developmental Endpoints in Three Strains of Female Rat Commonly Used in Mammary Carcinogenesis Studies: Implications for Timing of Carcinogen Exposure. Toxicol. Pathol. 44(7):1021-33. doi: 10.1177/0192623316655222. [Abstract Stanko JP, Kissling GE, Chappell VA, Fenton SE. 2016. Differences in the Rate of in situ Mammary Gland Development and Other Developmental Endpoints in Three Strains of Female Rat Commonly Used in Mammary Carcinogenesis Studies: Implications for Timing of Carcinogen Exposure. Toxicol. Pathol. 44(7):1021-33. doi: 10.1177/0192623316655222.]
  3. Stanko JP, Easterling MR, Fenton SE. 2015. Application of Sholl analysis to quantify changes in growth and development in rat mammary gland whole mounts. Reprod. Toxicol. 54:129-135. doi:10.1016/j.reprotox.2014.11.004. [Abstract Stanko JP, Easterling MR, Fenton SE. 2015. Application of Sholl analysis to quantify changes in growth and development in rat mammary gland whole mounts. Reprod. Toxicol. 54:129-135. doi:10.1016/j.reprotox.2014.11.004.]
  4. Dixon D, Reed CE, Moore AB, Gibbs-Flournoy EA, Hines EP, Wallace EA, Stanko JP, Lu Y, Jefferson WN, Newbold RR, Fenton SE. 2012. Histopathologic changes in the uterus, cervix and vagina of immature CD-1 mice exposed to low doses of perfluorooctanoic acid (PFOA) in a uterotrophic assay. Reprod. Toxicol. 33(4):506-12. [Abstract Dixon D, Reed CE, Moore AB, Gibbs-Flournoy EA, Hines EP, Wallace EA, Stanko JP, Lu Y, Jefferson WN, Newbold RR, Fenton SE. 2012. Histopathologic changes in the uterus, cervix and vagina of immature CD-1 mice exposed to low doses of perfluorooctanoic acid (PFOA) in a uterotrophic assay. Reprod. Toxicol. 33(4):506-12.]
  5. White SS, Stanko JP, Kato K, Calafat AM, Hines EP, Fenton SE. 2011. Gestational and chronic low-dose PFOA exposures and mammary gland growth and differentiation in three generations of CD-1 mice. Environ. Health Perspect. 119(8):1070-6. [Abstract White SS, Stanko JP, Kato K, Calafat AM, Hines EP, Fenton SE. 2011. Gestational and chronic low-dose PFOA exposures and mammary gland growth and differentiation in three generations of CD-1 mice. Environ. Health Perspect. 119(8):1070-6.]
  6. Macon MB, Villanueva LR, Tatum-Gibbs K, Zehr RD, Strynar MJ, Stanko JP, White SS, Helfant L, Fenton SE. 2011. Prenatal perfluorooctanoic acid exposure in CD-1 mice: low-dose developmental effects and internal dosimetry. Toxicol. Sci. 122(1):134-45. [Abstract Macon MB, Villanueva LR, Tatum-Gibbs K, Zehr RD, Strynar MJ, Stanko JP, White SS, Helfant L, Fenton SE. 2011. Prenatal perfluorooctanoic acid exposure in CD-1 mice: low-dose developmental effects and internal dosimetry. Toxicol. Sci. 122(1):134-45.]
  7. Stanko JP, Enoch RR, Rayner JL, Davis CC, Wolf D, Malarkey DE, and Fenton SE. 2010. Effects of Prenatal Exposure to a Low Dose Atrazine Metabolite Mixture on the Reproductive Development of Male Long Evans Rats. Reprod. Toxicol. 30(4):540-549. [Abstract Stanko JP, Enoch RR, Rayner JL, Davis CC, Wolf D, Malarkey DE, and Fenton SE. 2010. Effects of Prenatal Exposure to a Low Dose Atrazine Metabolite Mixture on the Reproductive Development of Male Long Evans Rats. Reprod. Toxicol. 30(4):540-549.]
  8. White SS, Kato K, Jia LT, Basden BJ, Calafat AM, Hines EP, Stanko JP, Wolf CJ, Abbott BD, Fenton SE. 2009. Effects of perfluorooctanoic acid on mouse mammary gland development and differentiation resulting from cross-foster and restricted gestational exposures. Reprod. Toxicol. 27:289-98. [Abstract White SS, Kato K, Jia LT, Basden BJ, Calafat AM, Hines EP, Stanko JP, Wolf CJ, Abbott BD, Fenton SE. 2009. Effects of perfluorooctanoic acid on mouse mammary gland development and differentiation resulting from cross-foster and restricted gestational exposures. Reprod. Toxicol. 27:289-98.]
  9. Reiner JL, Nakayama SF, Delinsky AD, Stanko JP, Fenton SE, Lindstrom AB, Strynar MJ. 2009. Analysis of PFOA in dosed CD1 mice: Part 1. Methods development for the analysis of tissues and fluids from pregnant and lactating mice and their pups. Reprod. Toxicol. 27:360-4. [Abstract Reiner JL, Nakayama SF, Delinsky AD, Stanko JP, Fenton SE, Lindstrom AB, Strynar MJ. 2009. Analysis of PFOA in dosed CD1 mice: Part 1. Methods development for the analysis of tissues and fluids from pregnant and lactating mice and their pups. Reprod. Toxicol. 27:360-4.]
  10. Suzanne E. Fenton, Jessica L. Reiner, Shoji F. Nakayama, Amy D. Delinsky, Jason P.Stanko, Erin P. Hines, Sally S. White, Andrew B. Lindstrom, Mark J. Strynar, Syrago-Styliani E. Petropoulou. 2009. Analysis of PFOA in dosed CD-1 mice. Part 2: Disposition of PFOA in tissues and fluids from pregnant and lactating mice and their pups. Reprod. Toxicol. 27:365-372. [Abstract Suzanne E. Fenton, Jessica L. Reiner, Shoji F. Nakayama, Amy D. Delinsky, Jason P.Stanko, Erin P. Hines, Sally S. White, Andrew B. Lindstrom, Mark J. Strynar, Syrago-Styliani E. Petropoulou. 2009. Analysis of PFOA in dosed CD-1 mice. Part 2: Disposition of PFOA in tissues and fluids from pregnant and lactating mice and their pups. Reprod. Toxicol. 27:365-372.]

Back
to Top